Keizo Asami Institute (iLIKA), Federal University of Pernambuco-UFPE, Recife 50670-901, PE, Brazil.
Department of Genetics, Federal University of Pernambuco-UFPE, Recife 50670-901, PE, Brazil.
Viruses. 2023 Feb 5;15(2):440. doi: 10.3390/v15020440.
Decades of studies in antiretroviral therapy (ART) have passed, and the mechanisms that determine impaired immunological recovery in HIV-positive patients receiving ART have not been completely elucidated yet. Thus, T-lymphocytes immunophenotyping and cytokines levels were analyzed in 44 ART-treated HIV-positive patients who had a prolonged undetectable plasma viral load. The patients were classified as immunological non-responders (INR = 13) and immunological responders (IR = 31), according to their CD4+ T cell levels. Evaluating pre-CD4+ levels, we observed a statistically significant trend between lower CD4+ T cell levels and INR status (Z = 3.486, < 0.001), and during 18 months of ART, the CD4+ T cell levels maintained statistical differences between the INR and IR groups (WTS = 37.252, < 0.001). Furthermore, the INRs were associated with an elevated age at ART start; a lower pre-treatment CD4+ T cell count and a percentage that remained low even after 18 months of ART; lower levels of recent thymic emigrant (RTE) CD4+ T cell (CD45RA + CD31+) and a naïve CD4+ T cell (CD45RA + CD62L+); higher levels of central memory CD4+ T cells (CD45RA-CD62L+); and higher immune activation by CD4+ expressing HLA-DR+ or both (HLA-DR+ and CD38+) when compared with IRs. Our study demonstrates that thymic exhaustion and increased immune activation are two mechanisms substantially implicated in the impaired immune recovery of ART-treated HIV patients.
抗逆转录病毒疗法(ART)已经研究了几十年,但仍未完全阐明决定接受 ART 的 HIV 阳性患者免疫恢复受损的机制。因此,对 44 例接受 ART 治疗且血浆病毒载量持续不可检测的 HIV 阳性患者进行了 T 淋巴细胞免疫表型和细胞因子水平分析。根据 CD4+T 细胞水平,将患者分为免疫无应答者(INR=13)和免疫应答者(IR=31)。评估 CD4+T 细胞前水平时,我们观察到 CD4+T 细胞水平与 INR 状态之间存在统计学显著趋势(Z=3.486, < 0.001),并且在 18 个月的 ART 期间,CD4+T 细胞水平在 INR 和 IR 组之间保持统计学差异(WTS=37.252, < 0.001)。此外,INR 与 ART 开始时年龄较大相关;治疗前 CD4+T 细胞计数较低,即使在 18 个月的 ART 后仍保持较低水平;近期胸腺迁出细胞(RTE)CD4+T 细胞(CD45RA+CD31+)和幼稚 CD4+T 细胞(CD45RA+CD62L+)的水平较低;中央记忆 CD4+T 细胞(CD45RA-CD62L+)水平较高;表达 HLA-DR+或 HLA-DR+和 CD38+的 CD4+细胞的免疫激活水平较高。我们的研究表明,胸腺耗竭和免疫激活增加是导致接受 ART 治疗的 HIV 患者免疫恢复受损的两个重要机制。